SynopsisThe global Glioblastoma Multiforme Treatment (GBM) market was valued at US$ 548.3 million in 2023 and is anticipated to reach US$ 996.4 million by 2030, witnessing a CAGR of 8.8% during the forecast period 2024-2030. North American market for Glioblastom.....
Synopsis The global Medical Heavy Ion Accelerator market size was valued at USD 7110 million in 2022 and is forecast to a readjusted size of USD 10580 million by 2029 with a CAGR of 5.8% during review period. The influence of COVID-19 and the Russia-Ukra.....
Synopsis Medical bath safety products are specialized equipment designed to enhance safety and accessibility in the bathroom for individuals with mobility challenges, disabilities, or other medical conditions. These products aim to reduce the risk of fal.....
Synopsis The global Veterinary Real-Time PCR Kit market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The Veterinary Real-Time PCR Kit is an in vitro vete.....
SynopsisMedical Hyperspectral Imaging (MHSI) can also support surgeons by offering them information that’s invisible to the naked eye – in real time. That medical hyperspectral image can be displayed on a screen. Or the hyperspectral information can be added as an ove.....
SynopsisTraumatic Brain Injury Diagnostic Equipment refers to specialized medical devices used to assess and diagnose injuries to the brain caused by trauma. These tools include imaging technologies like computed tomography (CT) scans and magnetic resonance imaging (M.....
SynopsisThe global Bronchopulmonary Dysplasia (BPD) Epidemiology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Bronchopulmonary Dys.....
SynopsisRespiratory and anesthesia disposables are medical devices designed for the treatment of respiratory disorders. The global Respiratory and Anesthesia Disposables market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 20.....
SynopsisThe global Live Attenuated Polio Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Live Attenuated Polio Vaccine is est.....
SynopsisHuman tissue plasminogen activator, purified, glycosylated, 355 residues purified from CHO cells. Retavase is considered a "third-generation" thrombolytic agent, genetically engineered to retain and delete certain portions of human tPA. The global Retepl.....
